Virginia bills · 2026 Regular Session
Virginia HB 516
Health insurance; coverage for non-opioid prescription drugs.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Marty Martinez (Democratic)
Summary
Official abstract published by the Virginia legislature· SUMMARY AS INTRODUCED
Health insurance; coverage for non-opioid prescription drugs. Prohibits a health insurance carrier from imposing any cost-sharing, prior authorization, step therapy, or other limitation on coverage of a covered non-opioid drug approved by the U.S. Food and Drug Administration for the treatment or management of pain that is more restrictive or less favorable to the enrollee relative to a covered opioid drug approved by the U.S. Food and Drug Administration for the treatment or management of pain.
Text versions
Roll-call votes
State vote data last updated Oct 15, 2026, 8:04 PM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Feb 3, 2026 House | Subcommittee recommends laying on the table | pass | Set your home in Virginia to see |
Actions
- Feb 18, 2026 · House
Left in Labor and Commerce - Feb 3, 2026 · House
Subcommittee recommends laying on the table (5-Y 4-N) - Jan 27, 2026 · House
Fiscal Impact Statement from Department of Planning and Budget (HB516) - Jan 19, 2026 · House
Assigned HCL sub: Subcommittee #1 - Jan 13, 2026 · House
Referred to Committee on Labor and Commerce - Jan 13, 2026 · House
Prefiled and ordered printed; Offered 01-14-2026 26101109D